JSI-287

N/A

Report date: 2022/01/05 15:24:33
NME

Base Information

Drug NameJSI-287
Drug Alias NameJSI-287
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMitogen-activated protein kinase; ERK1/ERK2 inhibitors
TargetsMitogen-activated protein kinase; ERK1/ERK2
Therapy Area/IndicationsAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesJS InnoPharm (Shanghai) Ltd
China Registration ClassN/A

Develop Information

Active CompaniesJS InnoPharm (Shanghai) Ltd
Inactive CompaniesN/A
Active IndicationsAutoimmune Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A